Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rebecca Clements

Pediatrics Alpharetta, GA Medical Doctor

NPI 1487882916 CMS profile 1202577

3400A Old Milton Parkway, Suite 330, Alpharetta, GA 30005

Open in the dashboard

General payments

$1,977

124 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rebecca Clements of Alpharetta, GA is reported in the CMS Open Payments database as having received $1,977 across 124 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $405 27
2024 General $411 29
2023 General $346 19
2022 General $320 18
2021 General $260 15
2020 General $94 6
2019 General $141 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rebecca Clements
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Rebecca Clements were reported at $405. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Rebecca Clements Pediatrics median Middle half National median
2019 $141 $86 $31–$183 $163
2020 $94 $49 $22–$110 $114
2021 $260 $68 $27–$158 $132
2022 $320 $77 $30–$173 $149
2023 $346 $88 $33–$190 $160
2024 $411 $94 $34–$206 $164
2025 $405 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Corium, Inc. $465 38 payments
  2. Tris Pharma Inc $309 17 payments
  3. GlaxoSmithKline, LLC. $177 10 payments
  4. Supernus Pharmaceuticals, Inc. $155 9 payments
  5. Ironshore Pharmaceuticals Inc. $132 6 payments
  6. Sanofi Pasteur Inc. $118 5 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $98 6 payments
  8. Neos Therapeutics, LP $92 6 payments
  9. kaleo, Inc. $72 5 payments
  10. Cranial Technologies, Inc $65 4 payments
  11. Other $296 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,977 124 payments
Products named General payments · program years 2019–2025
  1. Azstarys $465 38 payments
  2. Dyanavel XR $221 12 payments
  3. BEXSERO $177 10 payments
  4. Qelbree $120 7 payments
  5. VAXELIS $77 3 payments
  6. AUVI-Q $72 5 payments
  7. VYVANSE $70 4 payments
  8. JORNAY PM $70 3 payments
  9. PEDIARIX $66 3 payments
  10. Doc Band $65 4 payments
  11. Other $955 56 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

124 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record